Praful Ravi

ASCO in Real Time: Breaking Advances for Nuclear Medicine

Abstract placeholder. Drop in the official SNMMI session abstract once published.

Day and time to be confirmed against the SNMMI program.

1. What's the actual bottleneck right now, isotopes, hot cells, or trained technologists?
2. Where do you see PSMA-targeted therapy hitting its real ceiling, clinical or operational?
3. How are you handling dosimetry standardization across sites in your trials?

Generated by a mock model. Wired to Anthropic when the API key is in place.

What we're seeing

• FierceBiotech · 2026-07-18
  Praful Ravi cited in NEJM perspective on theranostic standardization
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• BioPharma Reporter · 2026-08-13
  Praful Ravi joins editorial board of European Journal of Nuclear Medicine
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Reuters Health · 2026-09-16
  Praful Ravi presents updated trial data at ASCO Annual Meeting
  The work builds on more than a decade of radiochemistry collaboration.
• Endpoints News · 2026-02-27
  Praful Ravi co-authors review on PSMA in Journal of Nuclear Medicine
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.